Tue 10/24/2017 07:20 ET
DJIA23273.9654.670.23%SOLAR23.000.492.13%GOLD1283.402.950.23%Shanghai3136.7734.501.10%
S&P 5002564.9810.260.40%BANKS26.620.020.08%OIL51.910.070.14%Nikkei21805.17109.030.50%
NASDAQ6586.8341.960.64%SEMI98.750.380.38%US/EU1.180.000.28%Futures2566.252.750.11%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Aldeyra Therapeutics, Inc - ALDX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ALDX
  
From: singhtelecom (Rep: 956)Date: 07/07/2017 08:52
Forum: Aldeyra Therapeutics, Inc - Msg #21Thread #673937218 (Rec: 0)
we are excited to commence Phase 3 clinical testing of our novel aldehyde trap, ADX-102, in noninfectious anterior uveitis," said Todd Brady, M.D., Ph.D., president and CEO. "NAU is a rare and potentially blinding ocular disorder that affects an estimated 150,000 patients in the United States. In contrast to corticosteroids, which are often used to treat NAU, ADX-102 does not appear to cause increases in intraocular pressure -- a precursor to glaucoma -- and thus may represent a safer therapeutic option than the current standard of care." ADX-102 and other product candidates generated from Aldeyra's aldehyde trap platform sequester and facilitate the degradation of aldehydes, a class of endogenously generated pro-inflammatory mediators. In a Phase 2 clinical trial in NAU, 0.5% topical ocular ADX-102 led to the resolution of inflammation to the same degree as corticosteroid therapy, but without the increases in intraocular pressure observed in corticosteroid-treated patients. The Phase 3 clinical trial is expected to enroll up to 100 NAU patients with active disease, randomized equally to receive either 0.5% topical ocular ADX-102 or vehicle for four weeks. Consistent with the Phase 2 trial, the primary endpoint will be the resolution of inflammation. Results of the Phase 3 trial are expected in the second half of 2018.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreALDX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ALDX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.